Navigation Links
US Patent Office Issues Patent for VG Life Sciences' Peptide for HIV Treatment
Date:10/31/2013

SANTA BARBARA, Calif., Oct. 31, 2013 /PRNewswire/ -- VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

(Logo: http://photos.prnewswire.com/prnh/20131031/LA07859LOGO)

The United States Patent and Trademark Office has issued on October 15, 2013 Patent No.: US 8,557,764 covering the VG Life Sciences' peptide VG1177 for treating HIV infection. The VG1177 peptide prevents the survival of pro-inflammatory cells under conditions where inflammation is unwanted, thereby allowing the body's natural containment systems to provide protection from harm.

The hallmarks of chronic HIV infections are chronic inflammation and loss of CD4 T cells. Thus this patent may have important implications for treating inflammation associated with HIV infection and AIDS.

The patent will be issued to the University of Colorado (CU) and has been licensed exclusively to VG Life Sciences as a result of the invention filed by VG Life Sciences' Lead Scientist, Dr. M. Karen Newell Rogers, PhD, during her tenure at the University of Colorado Colorado Springs.  Dr. Newell Rogers is currently at Texas A&M University College of Medicine and Baylor Scott and White Health Care.

The patent abstract reads as follows:

"The invention relates to methods for modulating the immune function through targeting of CLIP molecules as well as gamma delta T cells. The result is wide range of new therapeutic regimens for treating, inhibiting the development of, or otherwise dealing with, a multitude of illnesses and conditions, including autoimmune disease, transplant and cell graft rejection, cancer, bacterial infection, HIV infection, and AIDS, as well as novel methods of dia
'/>"/>

SOURCE VG Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Enbrel® (etanercept) Patent Issued
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
7. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
8. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
9. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... N.M., Dec. 12 Biomoda, Inc. (OTC,Bulletin Board: ... New,Mexico Institute of Mining and Technology (New Mexico ... to collaborate on clinical,studies and the development of ... commercialization of its assay for the early,detection of ...
... mg/Day Dose for PRISTIQ for the ... Treatment of Major Depressive Disorder, COLLEGEVILLE, Pa., ... WYE ), announces that data from,two Phase 3 clinical studies ... patients who received a 50 mg/day dose of PRISTIQ for ...
... expanding pipeline of products to ... treat ophthalmic diseases, ... developing novel therapeutics for the treatment,of ophthalmic diseases announced today ... a strong, international syndicate of new and,existing investors led by ...
Cached Biology Technology:Biomoda Announces Collaborative Agreement With New Mexico Tech 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6Fovea Pharmaceuticals Completes EUR30M Series B Financing 2Fovea Pharmaceuticals Completes EUR30M Series B Financing 3Fovea Pharmaceuticals Completes EUR30M Series B Financing 4
(Date:4/15/2014)... global experts who study the deadliest infectious diseases recognized ... Ksiazek, professors at the University of Texas Medical Branch, ... International Symposium on Filoviruses. The filoviruses include Ebola and ... percent of people infected. The current outbreak of Ebola ... 100 deaths so far. , "This award represents ...
(Date:4/15/2014)... Zealand,s pastoral landscapes are some of the loveliest in ... Many of the country,s pasture soils have become enriched ... which is then eaten by the cattle and sheep ... New Zealand; cadmium-enriched soils being reported worldwide. , The ... levels in meat and dairy products, human health and ...
(Date:4/15/2014)... Sciences (KNAW) has announced the names of five internationally ... (one million US dollars prize money in total). The ... to science. , This year marks the 50th anniversary ... chemist Erwin Chargaff in 1964. , KNAW juries ... laureates: , Christopher M. Dobson, John Humphrey ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Five scientists awarded prestigious Heineken Prizes 2
... and Molecular Biology of Universitat Autnoma de Barcelona ... with a tendency to cause conformational diseases such ... amyloidotic cardiomyopathy, etc. finally end up causing them. ... 3D structure and studied why these proteins finally ...
... protein found present in all cells in the body could ... at the University of Edinburgh have found that the protein ... in lipid droplets the parts of cells used to ... of invadolysin were linked to reduced amounts of fat deposits. ...
... was a frightening failure in drug safety processes. In ... died after being administered contaminated doses of the common ... in China and discovered with the help of scientists ... pure heparin that is was undetectable to all but ...
Cached Biology News:Mechanism related to the onset of various genetic diseases revealed 2Mechanism related to the onset of various genetic diseases revealed 3Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals 2Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals 3
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
...
... and disposable ESI Chip allow users to ... electrospray mass spectrometers for life science applications. ... to either speed analysis for increased throughput ... or long acquisition times for proteomics and ...
... are optimised for SYBR Green I assays and ... PCR, with the exception of template and primers. ... levels of active SYBR Green I dye and ... buffer that enables detection of low copy number ...
Biology Products: